Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Accumulated Depreciation & Amortization (2016 - 2025)

Bio-Techne (TECH) has 15 years of Accumulated Depreciation & Amortization data on record, last reported at $289.0 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 8.94% year-over-year to $289.0 million; the TTM value through Sep 2025 reached $289.0 million, up 8.94%, while the annual FY2025 figure was $286.1 million, 11.53% up from the prior year.
  • Accumulated Depreciation & Amortization reached $289.0 million in Q3 2025 per TECH's latest filing, up from $286.1 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $289.0 million in Q3 2025 and bottomed at $186.9 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 4 years is $239.1 million, with a median of $242.8 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: grew 12.36% in 2021, then increased 8.94% in 2025.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $201.1 million in 2021, then increased by 16.22% to $233.7 million in 2023, then grew by 13.5% to $265.3 million in 2024, then rose by 8.94% to $289.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $289.0 million in Q3 2025, $286.1 million in Q2 2025, and $265.3 million in Q3 2024.